What is enGene Therapeutics Inc. Common Stock's Market Cap?

enGene Therapeutics Inc. Common Stock's Market Cap is $128.6M, based on as-reported figures from SEC (XBRL) filings.

What is enGene Therapeutics Inc. Common Stock's Enterprise Value?

enGene Therapeutics Inc. Common Stock's Enterprise Value is -$129.8M, based on as-reported figures from SEC (XBRL) filings.

What is enGene Therapeutics Inc. Common Stock's EV / EBITDA?

enGene Therapeutics Inc. Common Stock's EV / EBITDA is 1.0×, based on as-reported figures from SEC (XBRL) filings.

What is enGene Therapeutics Inc. Common Stock's Net Income (TTM)?

enGene Therapeutics Inc. Common Stock's Net Income (TTM) is -$126.8M, based on as-reported figures from SEC (XBRL) filings.

What is enGene Therapeutics Inc. Common Stock's EBITDA?

enGene Therapeutics Inc. Common Stock's EBITDA is -$131.9M, based on as-reported figures from SEC (XBRL) filings.

What is enGene Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

enGene Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -1.89, based on as-reported figures from SEC (XBRL) filings.

What is enGene Therapeutics Inc. Common Stock's Net Debt?

enGene Therapeutics Inc. Common Stock's Net Debt is -$258.5M, based on as-reported figures from SEC (XBRL) filings.

enGene Therapeutics Inc. Common Stock (ENGN) Financial Statements

enGene Therapeutics Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG01J1GCYX6

XNAS · usd

1.92▲ 0.10 (5.49%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.82

Day's Range1.78 – 1.94

52-Week Range1.40 – 12.25

Volume1.5M

Avg Volume698.4K

Share Statistics

Shares Outstanding

Employees82

ExchangeXNAS

Listed2023-11-01

Share count as of June 9, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about enGene Therapeutics Inc. Common Stock (ENGN)

What is enGene Therapeutics Inc. Common Stock's Market Cap?: enGene Therapeutics Inc. Common Stock's Market Cap is $128.6M, based on as-reported figures from SEC (XBRL) filings.
What is enGene Therapeutics Inc. Common Stock's Enterprise Value?: enGene Therapeutics Inc. Common Stock's Enterprise Value is -$129.8M, based on as-reported figures from SEC (XBRL) filings.
What is enGene Therapeutics Inc. Common Stock's EV / EBITDA?: enGene Therapeutics Inc. Common Stock's EV / EBITDA is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is enGene Therapeutics Inc. Common Stock's Net Income (TTM)?: enGene Therapeutics Inc. Common Stock's Net Income (TTM) is -$126.8M, based on as-reported figures from SEC (XBRL) filings.
What is enGene Therapeutics Inc. Common Stock's EBITDA?: enGene Therapeutics Inc. Common Stock's EBITDA is -$131.9M, based on as-reported figures from SEC (XBRL) filings.
What is enGene Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: enGene Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -1.89, based on as-reported figures from SEC (XBRL) filings.
What is enGene Therapeutics Inc. Common Stock's Net Debt?: enGene Therapeutics Inc. Common Stock's Net Debt is -$258.5M, based on as-reported figures from SEC (XBRL) filings.